Introduction to the consensus recommendations

Affiliations

¹ Vancouver, Canada; Boca Raton, Fla.; and San Francisco, Calif. From the Department of Ophthalmology, University of British Columbia; private practice; and the Department of Dermatology, University of California School of Medicine, San Francisco.

Jean Carruthers et al. Plast Reconstr Surg. 2004 Nov.

. 2004 Nov;114(6 Suppl):i-iii.

doi: 10.1097/01.PRS.0000146690.73307.EF.

¹ Vancouver, Canada; Boca Raton, Fla.; and San Francisco, Calif. From the Department of Ophthalmology, University of British Columbia; private practice; and the Department of Dermatology, University of California School of Medicine, San Francisco.

No abstract available

References

1. Leffell, D. J. Foreword. In M. S. Kaminer, J. S. Dover, and K. A. Arndt (Eds.), Atlas of Cosmetic Surgery, 1st Ed. Philadelphia: Saunders, 2002. Pp. ix-x.
1. Carruthers, A., and Carruthers, J. The treatment of glabellar furrow with botulinum A exotoxin. J. Dermatol. Surg. Oncol. 16: 83, 1990.
1. Carruthers, J. D., and Carruthers, J. A. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J. Dermatol. Surg. Oncol. 18: 17, 1992.
1. Klein, A. W. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatol. Surg. 29: 549, 2003.
1. Fagien, S. Botulinum toxin type A for facial aesthetic enhancement: Role in facial shaping. Plast. Reconstr. Surg. 112 (Suppl.): 6S, 2003.